Imagion Biosystems Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It is involved in the nanotechnology; biotechnology; and cancer diagnostics businesses. The company develops MagSense, which completed Phase 1 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to detect cancer. The company has collaboration with Siemens MRI to support the Phase 2 study of MagSense HER2 imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
-
Beta
-0.16
Market cap
$12.26M
Enterprise value
$7.25M
Company profile
| Industry / Sector | Diagnostics & Research / Healthcare |
|---|---|
| Website | https://imagionbiosystems.com |
| Mailing address | Suite 2 Level 11 385 Bourke Street Melbourne VIC 3000 Australia |
| Phone / Fax | 61 3 9692 7222 / |
Dividends
More: Imagion Biosystems Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Imagion Biosystems paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IBX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Imagion Biosystems.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Robert Romeo Proulx | Executive Chairman | 67 | |
| Ms. Melanie Leydin C.A. | Non-Executive Director & Company Secretary | ||
| Mr. Ward Detwiler | Chief Business Officer |
Profitability and management effectiveness
Profit margin
-208.52%
Operating margin
-4475.07%
Return on assets
-83.89%
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Imagion Biosystems is 12.26M and its enterprise value is 7.25M. The enterprise value to revenue ratio of IBX is 6.87. The enterprise value to EBITDA ratio of IBX is -5.54.
Companies similar to Imagion Biosystems (IBX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Imagion Biosystems (ASX:IBX) Frequently Asked Questions
1. What is Imagion Biosystems's Stock Symbol?
Imagion Biosystems trades on ASX under the ticker symbol "IBX".
2. What is Imagion Biosystems's stock price today?
One share of IBX stock can currently be purchased for approximately $0.025.
3. How can I contact Imagion Biosystems?
Imagion Biosystems's mailing address is Suite 2 Level 11 385 Bourke Street Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9692 7222.
4. What is Imagion Biosystems's official website?
The official website of Imagion Biosystems is https://imagionbiosystems.com.